Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen

By Yilmaz Aylin   Ståhle Lars   Hagberg Lars   Svennerholm Bo   Fuchs Dietmar   Gisslén Magnus  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 11-12, 2004-12 ,pp. : 823-828

Informa Healthcare

Access to resources Recommend Favorite

Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial

By Andersson Lars-Magnus  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 7, 2013-07 ,pp. : 543-551

Informa Healthcare

Access to resources Recommend Favorite

Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir

By Calza Leonardo   Trapani Filippo   Salvadori Caterina   Magistrelli Eleonora   Manfredi Roberto   Colangeli Vincenzo   Di Bari Maria Assunta   Borderi Marco   Viale Pierluigi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 147-154

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïïve human immunodeficiency virus-1 patients in Sweden

By Thuresson Per-Olof   Heeg Bart   Lescrauwaet Benedicte   Sennfäält Karin   Alaeus Annette   Neubauer Aljoscha  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 4, 2011-04 ,pp. : 304-312

Informa Healthcare

Access to resources Recommend Favorite

Primary Herpes simplex Virus Type 1 Gingivostomatitis During the Second and Third Trimester of Pregnancy: Foetal and Pregnancy Outcome

By Pardo Joseph   Yogev Yariv   Ben-haroush Avraham   Hod Moshe   Amir Jacob  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 3, 2004-04 ,pp. : 179-181

Informa Healthcare

Access to resources Recommend Favorite